<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestim</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной  академии наук Беларуси. Серия медицинских наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Medical series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-6023</issn><issn pub-type="epub">2524-2350</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vestim-396</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ЭКСПЕРИМЕНТАЛЬНАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND EXPERIMENTAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>ПРОГНОЗ НАДЖЕЛУДОЧКОВОЙ ТАХИКАРДИИ У ПАЦИЕНТОВ, ПОЛУЧАЮЩИХ СУПРЕССИВНУЮ ТЕРАПИЮ L-ТИРОКСИНОМ</article-title><trans-title-group xml:lang="en"><trans-title>PREDICTION OF SUPRAVENTRICULAR TACHYCARDIA IN PATIENTS UNDERWENT L-THYROXINE SUPPRESSIVE THERAPY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митюкова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mityukova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. биол. наук, вед. науч. сотрудник</p><p>ул. Академическая, 28, 220072</p></bio><bio xml:lang="en"><p>Ph. D. (Biol.), Leading researcher</p><p>28, Akademicheskaya Str., 220072</p></bio><email xlink:type="simple">mityukovat@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мороз</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Moroz</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, доцент, декан</p><p>пр. Дзержинского, 83, 220116</p></bio><bio xml:lang="en"><p>D. Sc. (Med.), Assistant Professor, Dean</p><p>83, Dzerzhynskiy Ave., 220116</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леонова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Leonova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, заведующий отделением</p><p>ул. Академическая, 2, 220072</p></bio><bio xml:lang="en"><p>Ph. D. (Med.), Head of the Department</p><p>2, Akademicheskaya Str., 220072</p></bio><email xlink:type="simple">avinir@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Безлер</surname><given-names>Ж. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bezler</surname><given-names>J. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, доцент</p><p>пр. Дзержинского, 83, 220116</p><p> </p></bio><bio xml:lang="en"><p>Ph. D. (Med.), Assistant Professor</p><p>83, Dzerzhynskiy Ave., 220116</p></bio><email xlink:type="simple">bezler@tut.by</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кохан</surname><given-names>С. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kohan</surname><given-names>S. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>науч. сотрудник</p><p>ул. Академическая, 28, 220072</p><p> </p></bio><bio xml:lang="en"><p>Researcher</p><p>28, Akademicheskaya Str., 220072</p></bio><email xlink:type="simple">Skohan@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт физиологии НАН Беларуси, Минск</institution></aff><aff xml:lang="en"><institution>Institute of Physiology of the National Academy of Sciences of Belarus, Minsk</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет, Минск</institution></aff><aff xml:lang="en"><institution>Belarusian State Medical University, Minsk</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Минский городской клинический онкодиспансер, Минск</institution></aff><aff xml:lang="en"><institution>Minsk City Clinical Oncological Dispensary, Minsk</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2017</year></pub-date><volume>0</volume><issue>4</issue><fpage>17</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Митюкова Т.А., Мороз И.Н., Леонова Т.А., Безлер Ж.А., Кохан С.Б., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Митюкова Т.А., Мороз И.Н., Леонова Т.А., Безлер Ж.А., Кохан С.Б.</copyright-holder><copyright-holder xml:lang="en">Mityukova T.A., Moroz I.N., Leonova T.A., Bezler J.A., Kohan S.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestimed.belnauka.by/jour/article/view/396">https://vestimed.belnauka.by/jour/article/view/396</self-uri><abstract><p>Известно, что лечение пациентов с тиреоидным раком включает проведение супрессивной терапии L-тироксином. Наиболее частыми осложнениями субклинического гипертиреоза, возникающего при лечении, являются нарушения сердечного ритма и, в частности, тахикардия.</p><p>Цель исследования – разработать прогностическую модель расчета развития наджелудочковой тахикардии у молодых пациентов (20–44 года), длительное время (более 5 лет) получающих супрессивную терапию L-тироксином.</p><p>Предложена логит-регрессионная модель, описывающая индивидуальный прогноз развития наджелудочковой тахикардии в зависимости от пола, показателей вариабельности сердечного ритма (CV, SI) и уровня свободного тироксина. Расчетное значение прогностического показателя Y позволяет выявлять пациентов, имеющих высокую вероятность развития заболевания, и проводить снижение дозы L-тироксина, учитывая целевые значения тиреотропного гормона. В работе проводится анализ контролируемых показателей у пациентов как с благоприятным, так и с неблагоприятным прогнозом развития заболевания. </p></abstract><trans-abstract xml:lang="en"><p>It is known that the treatment of patients with thyroid cancer includes a need for suppressive therapy with L-thyroxine. The most frequent complications of subclinical hyperthyroidism arising during treatment are cardiac arrhythmias and, in particular tachycardia.</p><p>The goal is to develop a prognostic model for calculating the development of supraventricular tachycardia in young patients (20–44 years) who were subjected to L-thyroxine suppressive therapy for a long time (more than 5 years).</p><p>A logit-regression model is proposed for description of an individual prognosis of development of supraventricular tachycardia depending on sex, heart rate variability (CV, SI) and a free thyroxine level. The estimated value of the prognostic indicator Y allows one to identify patients with a high probability of developing a disease and to reduce a dose of L-thyroxine, taking into account the target values of the thyroid-stimulating hormone. The work analyzes the monitored indicators related to a favorable or unfavorable prognosis of development of the disease. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>cупрессивная терапия L-тироксином</kwd><kwd>прогноз наджелудочковой тахикардии</kwd><kwd>вариабельность сердечного ритма</kwd><kwd>уровень свободного тироксина в крови</kwd></kwd-group><kwd-group xml:lang="en"><kwd>suppressive therapy with L-thyroxine</kwd><kwd>prognosis of supraventricular tachycardia</kwd><kwd>heart rate variability</kwd><kwd>free thyroxine level in blood</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer / D.S. Cooper [et al.] // Thyroid. – 2009. – Vol. 19, N 11. – P. 1167–1214.</mixed-citation><mixed-citation xml:lang="en">Cooper D. S., Doherty G. M., Haugen B. R., Kloos R. T., Lee S. L., Mandel S. J., Mazzaferri E. L., Mclver B., Pacini F., Schlumberger M., Sherman S. I., Steward D. L., Tuttle R.M. Revised management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, vol. 19, no. 11, pp. 1167–1214.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium / F. Pacini [et al.] // Eur. J. Endocrinol. – 2006. – Vol. 54, N 6. – P. 787–803.</mixed-citation><mixed-citation xml:lang="en">Pacini F., Schlumberger M., Dralle H., Elisei R., Smit J.W. A., Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology, 2006, vol. 54, no. 6, pp. 787–803. DOI: 10.1530/eje.1.02158</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Румянцев, П.О. Современные принципы терапии L-тироксином после операции у больных высокодифференцированным раком щитовидной железы / П.О. Румянцев, С.В. Коренев, У.В. Румянцева // Опухоли головы и шеи. – 2013. – №2. – С. 5–8.</mixed-citation><mixed-citation xml:lang="en">Rumiantsev P. O., Korenev S. V., Rumiantseva U.V. The modern principles of therapy the levotiroksiny ambassador of operation at patients with the high-differentiated cancer of a thyroid gland. Opukholi golovy i shei [Head and Neck Tumors], 2013, no. 2, pp. 5–8 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Алгоритмы диагностики и лечения злокачественных новообразований / под ред. О.Г. Суконко, С.А. Красного. – Минск : Проф. изд., 2012. – С. 440–451.</mixed-citation><mixed-citation xml:lang="en">Algorithms of diagnostics and treatment of malignant new growths, in Sukonko O. G., Krasny S. A. (ed.). Minsk, Professional’nye izdaniya Publ., 2012, pp. 440–451 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Biondi, B. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer / B. Biondi, D.S. Cooper // Thyroid. – 2010. – Vol. 20, N 2. – P. 135–145.</mixed-citation><mixed-citation xml:lang="en">Biondi B., Cooper D.S. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid, 2010, vol. 20, no. 2, pp. 135–145. DOI: 10.1089/thy.2009.0311</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Бокерия, О.Л. Фибрилляция предсердий при субклинической форме гипертиреоза (патогенез, клиника, лечение, прогноз) / О.Л. Бокерия, И.В. Волковская // Анналы аритмологии. – 2013. – Т. 10, №4. – С. 201–209.</mixed-citation><mixed-citation xml:lang="en">Bokeriia O. L., Volkovskaia I.V. Fibrillation of auricles at a subclinical form of a gipertireoz (pathogenesis, clinic, treatment, forecast). Annaly aritmologii [Annals of Arrhythmology], 2013, vol. 10, no. 4, pp. 201–209 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Влияние тироксина на сердечно-сосудистую систему и рецепцию трийодтиронина у пациентов с карциномой щитовидной железы / Т. А. Митюкова [и др.] // Вес. Нац. акад. навук Беларусi. Сер. мед. навук. – 2010. – №1. – C. 92–98.</mixed-citation><mixed-citation xml:lang="en">Mitiukova T. A., Drozd V. M., Leonova T. A., Platonova T. Iu., Bezler Zh. A., Tuzova A. A., Lushchik M.L. Influence of a thyroksine on cardiovascular system and reception of a triyodothironine at patients with a carcinoma of a thyroid gland. Vestsі Natsyianal’nai akademіі navuk Belarusі. Seryia medytsynskіkh navuk = Proceedings of the National Academy of Sciences of Belarus. Medicine series, 2010, no. 1, pp. 92–98 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мрочек, А.Г. Избранные аспекты состояния сердечно-сосудистой системы на фоне субклинического гипертиреоза / А.Г. Мрочек, С.Н. Артишевский // Мед. панорама. – 2003. – №2. – C. 7–9.</mixed-citation><mixed-citation xml:lang="en">Mrochek A. G., Artishevskii S.N. The chosen aspects of a condition of cardiovascular system against the background of a subclinical gipertireoz. Meditsinskaia panorama [Medical Panorama], 2003, no. 2, pp. 7–9 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем / Р.М. Баевский [и др.] // Вестн. аритмологии. – 2001. – №24. – C. 65–87.</mixed-citation><mixed-citation xml:lang="en">Baevskii R. M., Ivanov G. I., Chireikin L. V., Gavrilushkin A. P., Dovgalevskii P. Ia., Kukushkin Iu. A., Mironova T. F., Prilutskii D. A., Semenonov Iu. N., Fedorov V. F., Fleishman A. N., Medvedev M.M. The analysis of variability of heart rhythm when using various electrocardiographic systems. Vestnik aritmologii [Messenger of Aritmology], 2001, no. 24, pp. 65–87 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Фролов, А.В. Контроль механизмов адаптации сердечной деятельности в клинике и спорте. – Минск : Полипринт, 2011. − 216 с.</mixed-citation><mixed-citation xml:lang="en">Frolov A.V. Control of mechanisms of adaptation of heart activity in clinic and sport. Minsk, Poliprint Publ., 2011. 216 p. (in Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
